ArticleCyborg and bionic systems (Washington, D.C.)2024
A Biological Immunity-Based Neuro Prototype for Few-Shot Anomaly Detection with Character Embedding.
Article in Cyborg and bionic systems (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 14 citations in OpenAlex.
- Functionalized polysaccharides for infection-resistant and regenerative therapies in gynecology.International journal of pharmaceutics: X · 2026Review
- Communication Tapestry: Health Literacy Mediates Public Trust in Physician Health Information in Pakistani Public Hospitals.Healthcare (Basel, Switzerland) · 2025Article
- Designing of multi-epitope vaccine against Varicella zoster virus (VZV) using immunoinformatics and structural analysis: In silico study.BioImpacts : BI · 2025Article
- The role of artificial intelligence in enhancing breast cancer screening and diagnosis: A review of current advances.BioImpacts : BI · 2025Review
- Reviving Dormant Immunity: Millimeter Waves Reprogram the Immunosuppressive Microenvironment to Potentiate Immunotherapy without Obvious Side Effects.Cyborg and bionic systems (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anomaly detection has wide applications to help people recognize false, intrusion, flaw, equipment failure, etc. In most practical scenarios, the amount of the annotated data and the trusted labels is low, resulting in poor performance of the detection. In this paper, we focus on the anomaly detection for the text type data and propose a detection network based on biological immunity for few-shot detection, by imitating the working mechanism of the immune system of biological organisms. This network enabling the protected system to distinguish the aggressive behavior of "nonself" from the legitimate behavior of "self" by embedding characters. First, it constructs episodic task sets and extracts data representations at the character level. Then, in the pretraining phase, Word2Vec is used to embed the representations. In the meta-learning phase, a dynamic prototype containing encoder, routing, and relation is designed to identify the data traffic. Compare to the mean-based prototype, the proposed prototype applies a dynamic routing algorithm that assigns different weights to samples in the support set through multiple iterations to obtain a prototype that combines the distribution of samples. The proposed method is validated on 2 real traffic datasets. The experimental results indicate that (a) the proposed anomaly detection prototype outperforms state-of-the-art few-shot techniques with 1.3% to 4.48% accuracy and 0.18% to 4.55% recall; (b) under the premise of ensuring the accuracy and recall, the number of training samples is reduced to 5 or 10; (c) ablation experiments are designed for each module, and the results show that more accurate prototypes can be obtained by using the dynamic routing algorithm.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.